| ABS INTERNATIONAL |
Implementing antibiotic strategies (ABS) for appropriate use of antibiotics in hospitals in member states of the European Union |
| ACE |
Approaches to control multi-resistant enterococci: studies on molecular ecology, horizontal gene transfer, fitness and prevention |
| ACE-ART |
Assessment and critical evaluation of antibiotic resistance transferability in food chain |
| ActinoGEN |
Integrating genomics-based applications to exploit actinomycetes as a resource for new antibiotics |
| AMIS |
Antimicrobials by immune stimulation |
| ANTIBIOTARGET |
Molecular and functional genomic approaches to novel antibacterial target discovery |
| BACELL HEALTH |
Bacterial stress management relevant to infectious disease and biopharmaceuticals |
| BURDEN |
Burden of resistance and disease in European nations |
| CanTrain |
Host-pathogen interaction systems as tools to identify antifungal targets in C. albicans and C. dubliniensis |
| CHAMP |
Changing behaviour of healthcare professionals and the general public towards a more prudent use of anti-microbial agents |
| COBRA |
Combating resistance to antibiotics by broadening the knowledge on molecular mechanisms behind resistance to inhibitors of cell wall synthesis |
| COMBIG-TOP |
Combinatorial biosynthesis of industrial glycopeptides: technology, optimization and production |
| CombiGyrase |
Development of new gyrase inhibitors by combinatorial biosynthesis |
| CRAB |
Combating resistance to antibiotics |
| DRESP2 |
Role of mobile genetic elements in the spread of antimicrobial drug resistance |
| EACCAD |
European approach to combat outbreaks of Clostridium difficile associated diarrhoea by development of new diagnostic tests |
| EAR |
Effects of antibiotic resistance on bacterial fitness, virulence and transmission |
| EARSS |
The European antimicrobial resistance surveillance system |
| e-Bug |
Development and dissemination of a school antibiotic and hygiene education pack and website across Europe |
| ERAPharm |
Environmental risk assessment of pharmaceuticals |
| ESAC |
European surveillance of antimicrobial consumption |
| ESSTI |
European surveillance of sexually transmitted infections |
| ET-PA |
Enabling techniques for the development of a novel class of protein antibiotics |
| EUCAST |
European committee on antimicrobial susceptibility testing |
| EU-IBIS |
Invasive bacterial infections surveillance in European Union |
| EURESFUN |
Integrated post-genomic approaches for the understanding, detection and prevention of antifungal drug resistance in fungal pathogens |
| EuResist |
Integration of viral genomics with clinical data to predict response to anti-HIV treatment |
| EUR-INTAFAR |
Inhibition of new targets for fighting antibiotic resistance |
| Eurofungbase |
Strategy to build up and maintain an integrated sustainable European fungal genomic database required for innovative genomics research on filamentous fungi important for biotechnology and human health |
| EPG |
European virtual institute for functional genomics of bacterial pathogens - EuroPathoGenomics |
| EuropeHIVResistance |
European cohort coordinating network on HIV drug resistance |
| EuroTB |
Surveillance of tuberculosis in Europe |
| FUNGWALL |
The fungal cell wall as a target for antifungal therapies |
| GENOSEPT |
Genetics of sepsis in Europe |
| GRACE |
Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe |
| HAPPY AUDIT |
Health alliance for prudent prescribing, yield and use of antimicrobial drugs in the treatment of respiratory tract infections |
| IPSE |
Improving patient safety in Europe |
| LeishEpiNetSA |
Control strategies for visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) in South America: applications of molecular epidemiology |
| MagRSA |
Fully automated and integrated microfluidic platform for real-time molecular diagnosis of methicillin-resistant Staphylococcus aureus |
| MalariaPorin |
Validation of the plasmodium aquaglyceroporin as a drug target |
| MANASP |
Development of novel management strategies for invasive aspergillosis |
| micro-MATRIX |
micro-MATRIX: Workshop on strategies to address antimicrobial resistance through the exploitation of microbial genomics |
| MOSAR |
Mastering hospital antimicrobial resistance and its spread into the community |
| NewHiv Targets |
Identifying novel classes of HIV inhibitors |
| NEWTBDRUGS |
New drugs for persistent tuberculosis: exploitation of 3D structure of novel targets, lead optimisation and functional in vivo evaluation |
| NM4TB |
New medicines for tuberculosis |
| NPARI |
Tailoring of novel peptide coatings and therapeutics derived from a newly identified component of the human innate immunity against resistant infections |
| Phagevet-P |
Veterinary phase therapies as alternatives to antibiotics in poultry production |
| PNEUMOPEP |
New methods of treatment of antibiotic-resistant pneumococcal disease |
| PREVIS |
Pneumococcal resistance epidemicity and virulence – an international study |
| READ-UP |
Redox antimalarial drug discovery |
| REBAVAC |
Novel opportunities to develop vaccines to control antibiotic resistant bacteria: from the trials back to the laboratory |
| REPLACE |
Plants and their extracts and other natural alternatives to antimicrobials in feeds |
| SAFEWASTES |
Evaluating physiological and environmental consequences of using organic wastes after technological processing in diets for livestock and humans |
| SavinMucoPath |
Novel therapeutic and prophylactic strategies to control mucosal infections by South American bacterial strains |
| SIGMAL |
Targeting malaria transmission through interference with signalling in Plasmodium falciparum gametocytogenesis |
| SLIC |
Biosensors in molecular diagnostics nanotechnology for the analysis of species-specific microbial transcripts |
| StaphDynamics |
Functional genomic characterisation of molecular determinants for staphylococcal fitness, virulence and drug resistance |
| Tat machine |
Functional genomic characterisation of the bacterial Tat complex |
| TB Treatment Marker |
Establishing a TB treatment efficacy marker |
| TB-DRUG OLIGOCOLOR |
Development of a molecular platform for the simultaneous detection of Mycobacterium tuberculosis resistance to rifampicin and fluoroquinolones |
| TRAINAU |
Training risk assessment in non-human antimicrobial usage |
| TRIoH |
Targeting replication and integration of HIV |
| Tuberculosis China |
The diversity of Mycobacterium tuberculosis strains in China: tracing the origins of the worldwide dispersion of the multidrug-resistant Beijing genotype |
| UNITE-MORE |
Uniformity in testing and monitoring HIV resistance |
| VIRGIL |
European vigilance network for the management of antiviral drug resistance |
| VIROLAB |
A virtual lab for decision support in viral diseases treatment |
| VITBIOMAL |
Vitamin biosynthesis as a target for antimalarial therapy |
